bioAffinity Leadership Thursday, September 3, 2026 0.00 Neutral

bioAffinity CEO to present at H.C. Wainwright conference

CEO Maria Zannes will present a corporate update and meet with investors at the 28th Annual Global Investment Conference. This announcement details upcoming milestones for the CyPath Lung diagnostic test.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day